Industry-academia collaborations seminar series - Past Events

Previous seminars

Title: Biomarker-driven precision medicine

Cancer Research KI and LIF (The Swedish Association of the Pharmaceutical Industry) welcomed you to a joint seminar, followed by an after-work event with drinks.

LIF is the trade association for the research-based pharmaceutical industry in Sweden. LIF has about 90 member companies who represent approximately 80 percent of the total sales of pharmaceuticals in Sweden. Some of the members are AstraZeneca, GlaxoSmithKline, IQVIA, Ipsen, Merck, Roche and many more. The full list of member companies can be found here.

Date and Time: 4th of December 2024, 15:00-17:00h followed by AW

Location: Ragnar Granit, Biomedcium, Solna Campus

Agenda:

15.00-15.05  Welcome and introduction by Simon Ekman

15.05-15.25  Frida Lundmark from LIF: What is needed to move your project into the translational step.

15.25-16.00  Janne Lehtiö: Biomarker discovery

16.00-16.20  LIF pharma company Representative Sandra Eketorp Sylvan, Medical Director of Amgen: What is needed to move your project into clinical trial

16.20-17.00  Jeffrey Yachnin: Clinical trials

17:00-21:00  after-work with drinks and snacks

After-work Location: in the Biomedicum Faculty club on floor 10.

Title: Intellectual Property (IP)

The Swedish Intellectual Property Office - PRV representative Carl Hamsten discussed how to create value around IP as a researcher. Then Hans-Gustaf Ljunggren presented examples of IP and Richard Cowburn discussed things to consider when collaborating with industry. 

Date and Time: 4th of September 2024, 13:30-15:30 (Fika included)

Location: Peter Reichard, Biomedcium, Solna Campus

Agenda:

13.30 – 13:40 Welcoming words, Simon Ekman, Leader of the Industry Collaboration Working Group Cancer Research KI

13.40 – 14:20 "How to create value around IP as a researcher" Carl Hamsten, PRV  

14.20 – 14.40 "Experiences from starting up companies based on generated IP and academic-industrial collaborations at large", Hans-Gustaf Ljunggren, KI

14.40 – 14.55 Things to consider when collaborating with industry, Richard Cowburn, KI

14.55 – 15.30 Panel discussion and answers to questions

Title: Why and how to collaborate with industry

Date and TIme: 5th of February 2024, 12:00-14:00 (lunch included) 

Location: Ragnar Granit, Biomedcium, Solna Campus 

Agenda: 

12.00 Welcoming words, Simon Ekman Leader of the Industry Collaboration working group Cancer Research KI 

12.10 Why and how to collaborate with industry? Richard Cowburn and External Engagement office 

12.40 High-level examples of oncology companies from KI

12:40-13:00 Thomas Helleday, SciLifeLab, “From conceptualizing a cancer treatment to approved first line therapy - pitfalls and lucky strikes”. 

13:00-13:20 Mattias Rantalainen, "Bringing an AI-based precision diagnostic solution from academic research to a deployed medical device in clinic".

13:20-13:40 Hans Grönlund, "The Neogap story". 

13.40 Q&A 

14.00 Conclusions and final remarks

Programme for the seminar on the 23rd of March, 2023

Time: 13.00-15.30

Topic: Collaborate with academia, the company perspective.

Venue: Inghesalen Tomtebodavägen 18a, 171 65 Solna Campus (This event Will be in person). 

Programme 

13.00 Welcoming words by Simon Ekman

13.10 Elypta Francesco Gatto, Chief Science officer

13.30 Arne Östman and ROADS program Roche Anton Kraxner

13.50 KI Science Park Sara Gunnerås, Community Manager

14.10 NeoGap Hans Grönlund, Chief Science officer

14.30 Fika

14.45 Sprint BioSciences Martin Andersson Chief Scientific officer

15.05 Q&A with all presenters

15.30 end of seminar

Programme for the seminar on the 5th of December, 2022, Clinical Cancer Trials with an Emphasis on Early Experimental Studies and Collaboration with the Pharmaceutical Industry and Biotech companies

Speaker:  Jeffrey Yachnin,  Senior Consultant Karolinska Comprehensive Cancer Center Department of Clinical Cancer Studies, Cancer Theme, Karolinska University Hospital

Venue: Inghesalen Tomtebodavägen 18a, 171 65 Solna Campus or Zoom ( a link will be sent after registration)

Welcome to the hybrid seminar organised by Cancer Research KI. There will be time to discuss and ask questions during the afternoon. Please join either via zoom or in real life where fika will be served before the meeting. Details obtained after the registration.

Programme for the seminar on the 12th of October, 2022

Venue: Scheelesalen Tomtebodavägen 6, 171 65 Solna Campus or Zoom ( a link will be sent after registration)

Welcome to the hybrid seminar organised by Cancer Research KI. Swedish Intellectual Property Office (PRV) will give a talk about about how to create value around Intellectual Property (IP) as a researcher. Hans-Gustaf Ljunggren will  present a couple of examples of IP.

13.00 - 13.45 "How to create value around IP as a researcher" Carl Hamsten  

13.45 - 14.00 Examples by a researcher, Hans-Gustaf Ljunggren

14.00 -14.15 KI perspective, Richard Cowburn (how to deal with confidentiality, teachers perspective) 

14.15 - 15.00 Panel discussion and answers to questions

Programme for the seminar on the 19th of May, 2022, KI/Merck: existing and potential collaborations 

During this seminar, you will learn how Merck is looking to expand their ongoing collaboration with KI in the areas of oncology and immuno-oncology.  An ongoing project will also be presented. There will be time to discuss and ask questions during the afternoon.

13.45-14.00 : Coffee and networking

14.00-14.10 : Welcome and Introduction Simon Ekman (Cancer Research KI) and Sven Pötzsch (Merck Healthcare KGaA)

14.10- 14.30 : Richard Cowburn (KI) KI perspectives on Industry/Academia Partnerships the research area of Oncology 

14.30- 14.50 : Kahina Lang (Merck Healthcare KGaA)  Strategic Innovation at Merck: Motivation and Mission

14.50- 14.55: Short break

14.55- 15.15 : Eike-Benjamin Braune (KI)  Modulation of NOTCH Signaling as a new treatment option for solid tumors

15.15- 15.35 : Felix Geist (Merck Healthcare KGaA) Identification of a NOTCH transcriptomic signature for basal like breast cancer

15.35-15.55: Simon Ekman (Cancer Research KI), Richard Cowburn (KI) and Sven Pötzsch (Merck Healthcare KGaA) Open discussion

15.55: Closing remarks Simon Ekman

Programme for the seminar on January 20th, 2022

13.00 Welcoming words: Simon Ekman Leader of the Industrial collaboration working group CRKI

13.10 Why collaborate with industry? High-level examples of industrial relations KI have established within oncology: Richard Cowburn

14.00 Short break

14.10 KI processes and ways of working with industry: Richard Cowburn and External Engagement office

15.00 Conclusions and final remarks